Interspecific protoplast fusion between Candida utilis IAM 4277 and Candida lipolytica OUT 6340 was carried out. A stable fusant, No. 1, was selected from among many fusants which were able to grow on both maltose and n-hexadecane. Fusant No. 1 seems to be an intermediate between the parents with respect to morphological and physiological characteristics. Further chemotaxonomic studies on the coenzyme Q type, fatty acid composition and enzyme patterns, and antigenic analysis revealed that fusant No. 1 is a hybrid having both a major part of the characteristics of C. lipolytica OUT 6340 and a minor part of those of C. utilis IAM 4277.
In radical additional solution polymerization, the viscosity increases with reaction progress. It is important to evaluate beforehand the cooling capacity of the reactor, which worsens with the process.In this study, a stirred batch reactor with both a paddle and a helical screw impeller were studied, and measurements were made for the dynamic changes of the film heat transfer coefficient of the cooling coil with progress of the polymer reaction. We found the change could be evaluated by the calculating heat balance of the generated heat, the viscous dissipation energy and the sensible heat change under conditions of monomer conversion and changing viscosity.
Regional cerebral ischemia was produced in the rabbit by unilateral transorbital occlusion of the middle cerebral artery (procedure I); the middle cerebral and azygos anterior cerebral or anterior communicating artery (procedure II); or the middle cerebral, azygos anterior cerebral or anterior communicating, and internal carotid artery (procedure III). Evolution of ischemic lesions was examined with the immunohistochemical reaction for tubulin. With procedure I, ischemic lesions did not become constantly visible for 6 h in the basal ganglia and for 8 h in the frontoparietal region of the cerebral cortex. With procedure II, it was shortened to 3 h in the basal ganglia and to 6 h in the cerebral cortex. With procedure III, the ischemic lesions were observed in 1 h both in the basal ganglia and in the cerebral cortex as loss of the reaction for tubulin in the neuropil, nerve cell bodies, and dendrites. The evidence of neuronal damage became apparent in the same areas later by staining with hematoxylin–eosin. The experimental model presented here may be suitable for investigation of the mechanism that shifts reversible ischemia to cerebral infarction and for evaluation of the effectiveness of pharmacological intervention.
Flometoquin, 2-ethyl-3,7-dimethyl-6-[4-(trifluoromethoxy)phenoxy]quinolin-4-yl methyl carbonate, is a novel insecticide with a structurally unique phenoxy-quinoline. It was discovered in 2004 by the collaborative research of Nippon Kayaku and Meiji Seika Kaisha, Ltd. (currently, Mitsui Chemicals Crop & Life Solutions, Inc.). The compound demonstrates strong and quick insecticidal action against a variety of thrips species at the nymphal and adult stages through contact and feeding activity, which could minimize crop damage and economic loss by insect pest species. In addition, flometoquin is safe for tested non-target arthropods, which makes it suitable for controlling the insect pests mentioned above under Integrated Pest Management (IPM) programs. Here, we describe a structure-activity relationship study from lead generation to the discovery of flometoquin and its insecticidal properties, including knockdown activity and effects against non-targeted arthropods.
